Full name: Valeria Rios Rodriguez
Current country: Germany
Membership level: Associate
Type of membership: Member
Number of publications: 13
Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance (2021)
https://pubmed.ncbi.nlm.nih.gov/33832519/
Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33796155/
Diagnosing axial spondyloarthritis: estimation of the disease probability in patients with a priori different likelihoods of the diagnosis (2021)
https://pubmed.ncbi.nlm.nih.gov/33693503/
Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/32710108/
Relation of α 2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33317138/
Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa (2020)
https://pubmed.ncbi.nlm.nih.gov/32911279/
Comment on: ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al (2020)
https://pubmed.ncbi.nlm.nih.gov/32581089/
Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32447391/
Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31369867/
Response to: ‘Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?’ by Wallman et al (2019)
https://pubmed.ncbi.nlm.nih.gov/31818807/
Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept (2019)
https://pubmed.ncbi.nlm.nih.gov/30625261/
Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31126334/
Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis? (2017)
https://pubmed.ncbi.nlm.nih.gov/29338611/